abagovomab 51
abciximab 43
abituzumab 32
abrilumab 30
actoxumab 31
adalimumab 22
aducanumab 19
afasevikumab 24
alacizumab_pegol 17
alemtuzumab 39
alirocumab 29
amatuximab 57
andecaliximab 32
anifrolumab 33
anrukinzumab 25
aprutumab 23
aprutumab_ixadotin 23
arcitumomab 31
ascrinvacumab 20
atezolizumab 17
atinumab 23
avelumab 21
basiliximab 56
bavituximab 53
begelomab 42
benralizumab 40
bevacizumab_beta 30
bezlotoxumab 31
bimagrumab 33
bleselumab 30
blinatumomab 53
blosozumab 38
bococizumab 32
brazikumab 22
brentuximab_vedotin 48
briakinumab 25
brodalumab 30
brolucizumab 33
brontictuzumab 35
burosumab 32
cabiralizumab 38
camrelizumab 17
canakinumab 31
cantuzumab_ravtansin 58
carlumab 29
carotuximab 39
cergutuzumab_amunaleukin2 40
cergutuzumab_amunaleukin 40
certolizumab_pegol 28
cetiximab 55
citatuzumab_bogatox 31
cixutumumab 47
clivatuzumab_tetraxetan 36
codrituzumab 42
conatumumab 24
concizumab 35
crenezumab 26
crizanlizumab 36
crotedumab 26
dacetuzumab 26
daclizumab 29
dalotuzumab 48
dapirolizumab_pegol 31
daratumumab 18
dectrekumab 14
demcizumab 40
denosumab 14
depatuxizumab 35
depatuxizumab_mafodotin 35
dezamizumab 34
dinutuximab 47
diridavumab 39
domagrozumab 20
drozitumab 31
duligotuzumab 21
durvalumab 21
dusigitumab 41
efalizumab 38
efungumab 38
eldelumab 25
elezanumab 37
elgemtumab 15
elotuzumab 23
emactuzumab 33
emapalumab 32
emibetuzumab 33
enavatuzumab 29
enfortumab_vedotin 16
enoblituzumab 25
enokizumab 35
enoticumab 27
ensituximab 50
eptinezumab 21
erenumab 35
etaracizumab 19
etrolizumab 25
evinacumab 26
evolocumab 36
farletuzumab 18
fasinumab 32
fezakinumab 39
fibatuzumab 31
ficlatuzumab 38
firivumab 43
flanvotumab 31
fletikumab 40
foralumab 22
foravirumab 19
fremanezumab 35
fresolimumab 29
fulranumab 27
futuximab 46
galcanezumab 30
ganitumab 40
gantenerumab 18
gemetuzumab 43
gemtuzumab2 38
gemtuzumab 46
gevokizumab 33
girentuximab 41
glembatumumab 32
glembatumumab_vedotin 32
guselkumab 33
ibalizumab 44
ibritumomab 54
icrucumab 22
idarucizumab 51
ifabotuzumab 31
imalumab 19
imgatuzumab 32
inclacumab 26
indatuximab_ravtansin 45
indusatumab 28
inebilizumab 37
intetumumab 26
iodine_girentuximab 34
ipilimumab 13
iratumumab 23
isatuximab 47
itolizumab 33
ixekizumab 44
labetuzumab_govitecan 34
lambrolizumab 37
lampalizumab 35
lanadelumab 21
landogrozumab 21
laprituximab 41
lebrikizumab 45
lendalizumab 35
lenzilumab 30
lifastuzumab_vedotin 27
ligelizumab 34
lilotomab 53
lirilumab 36
lodelcizumab 32
lokivetmab 30
lorvotuzumab_mertansin 31
lucatumumab 33
lumretuzumab 36
lupartumab 24
lutikizumab 23
margetuximab 50
milatuzumab 51
mirvetuximab 50
mirvetuximab_soravtansin 50
modotuximab 55
mogamulizumab 37
monalizumab 36
motavizumab 45
moxetumomab_pasudotox 36
namilumab 36
naratuximab 40
naratuximab_emtansin 40
narnatumab 25
navicixizumab2 40
navicixizumab 41
navivumab 45
necitumumab 22
nemolizumab 39
nesvacumab 21
nivolumab 22
obiltoxaximab 36
obinutuzumab 45
ocaratuzumab 35
ofatumumab 24
olaratumab 31
olokizumab 29
omalizumab 23
onartuzumab 27
ontuxizumab 40
opicinumab 18
orticumab 17
otelixizumab 45
oxelumab 16
ozanezumab 46
pamrevlumab 15
panobacumab 33
parsatuzumab 33
pasotuxizumab 23
pateclizumab 24
patritumab 35
pembrolizumab 37
perakizumab 27
pidilizumab 31
pinatuzumab_vedotin 20
plozalizumab 38
pogalizumab 33
polatuzumab_vedotin 25
ponezumab 48
prezalumab 18
pritoxaximab 56
quilizumab 23
racotumomab 45
radretumab 20
ralpancizumab 35
ramucirumab 17
ranevetmab 39
ranibizumab 30
refanezumab 36
remtolumab 22
rilotumumab 32
rinucumab 34
risankizumab 47
rituximab 40
rivabazumab 28
robatumumab 22
roledumab 38
romosozumab 36
rontalizumab 27
rosmantuzumab 38
rozanolixizumab 31
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 34
sapelizumab 33
sarilumab 21
secukinumab 26
seribantumab 20
setoxaximab 57
sifalimumab 28
siltuximab 37
simtuzumab 38
sirukumab 19
solanezumab 29
solitomab 43
stamulumab 33
suptavumab 33
suvizumab 31
tabalumab 27
tadocizumab 27
tamtuvetmab 43
tanezumab 33
tarextumab 16
tavolixizumab 28
telisotuzumab 43
teplizumab 30
tesidolumab 41
tezepelumab 36
tigatuzumab 20
tildrakizumab 32
timolumab 21
tisotumab 18
tosatoxumab 53
tositumomab 53
tralokinumab 46
trastuzumab 26
tregalizumab 35
trevogrumab 19
ublituximab 45
urelumab 34
ustekinumab 35
utomilumab 42
vadastuximab 40
vadastuximab_talirin 40
vandortuzumab_vedotin 27
vantictumab 32
vanucizumab2 30
vanucizumab 52
varlilumab 21
vatelizumab 31
vedolizumab 42
veltuzumab 31
vesencumab 15
vorsetuzumab 39
vorsetuzumab_mafodotin 39
vunakizumab 50
xentuzumab 25
zatuximab 55
